Carisoprodol Tablet
Product Images NDC 50742-656

3 FDA label images from Ingenus Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 50742-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100's Label (Carisoprodol 100 V1)

100's Label (Carisoprodol 100 V1)
Label for Carisoprodol Tablets, USP 350 mg by Ingenus Pharmaceuticals, LLC. The label states the product contains 100 oral tablets and is prescription-only. It includes dosage, storage, and safety warnings alongside the NDC 50742-656-01 and a barcode. The label also shows the manufacturer's address in Orlando, FL.*
FDA Label Image

500's Label (Carisoprodol 500 V1)

500's Label (Carisoprodol 500 V1)
Label for Carisoprodol Tablets USP, 350 mg, oral tablets. The label shows the product name, strength, dosage form, quantity of 500 tablets, and the labeler Ingenus Pharmaceuticals, LLC. The NDC number 50742-656-05 and a barcode are also visible for identification and scanning purposes.*
FDA Label Image

Structure (Structure001)

Structure (Structure001)
Chemical structure of carisoprodol, the active ingredient in CARISOPRODOL tablets 350 mg by Ingenus Pharmaceuticals, LLC. The diagram shows the molecular arrangement including functional groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.